Literature DB >> 21509466

The role of lymph node dissection in the management of urothelial carcinoma of the upper urinary tract.

Tsunenori Kondo1, Kazunari Tanabe.   

Abstract

Urothelial carcinoma of the upper urinary tract (UCUUT) is a disease with poor prognosis and a high incidence of lymphatic metastasis at 30-40%. Lymphadenectomy may be a possible surgical strategy to control the spread of lymphatic cancer, but its therapeutic benefit in UCUUT has remained controversial in contrast to bladder cancer in which consensus has been almost reached with respect to the necessity of extended lymphadenectomy. We hypothesized that radical lymphadenectomy may also be important for UCUUT since UCUUT is histologically similar to bladder cancer. One of the major reasons for uncertainty about whether lymphadenectomy has any therapeutic value may have resulted from an incomplete understanding of the regional nodes. Thus, we started our analyses by clarifying this issue, and found that the primary sites of lymphatic metastases encompassed a relatively wide area, especially on the right side, when compared with the conventional recognition. We further reported complete lymphadenectomy in which all regional sites which were dissected appeared to provide a survival benefit for patients with UCUUT at an advanced stage. To date, several studies from the other institutes have added supportive evidence for the therapeutic role of lymphadenectomy. Although there are several points to be determined such as the extent of the template, the minimum number of lymph nodes removed, or the candidate for lymphadenectomy, performing lymphadenectomy is unlikely to have a negative effect on the patient. In the future, we expect that controlled prospective studies will further clarify the potential role of lymphadenectomy in UCUUT.

Entities:  

Mesh:

Year:  2011        PMID: 21509466     DOI: 10.1007/s10147-011-0234-2

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  41 in total

1.  Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy.

Authors:  H W Herr; S M Donat
Journal:  J Urol       Date:  2001-01       Impact factor: 7.450

2.  Renal lymphatic drainage and thoracic duct connections: implications for cancer spread.

Authors:  J Assouad; M Riquet; C Foucault; G Hidden; V Delmas
Journal:  Lymphology       Date:  2006-03       Impact factor: 1.286

3.  Primary carcinoma of the ureter: a prognostic study.

Authors:  M A Batata; W F Whitmore; B S Hilaris; N Tokita; H Grabstald
Journal:  Cancer       Date:  1975-06       Impact factor: 6.860

Review 4.  The role of lymphadenectomy in high-grade invasive bladder cancer.

Authors:  John P Stein; Donald G Skinner
Journal:  Urol Clin North Am       Date:  2005-05       Impact factor: 2.241

5.  Limitations of computed tomography in the preoperative staging of upper tract urothelial carcinoma.

Authors:  M J Scolieri; M L Paik; S L Brown; M I Resnick
Journal:  Urology       Date:  2000-12-20       Impact factor: 2.649

6.  Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base.

Authors:  Badrinath R Konety; Sue A Joslyn; Michael A O'Donnell
Journal:  J Urol       Date:  2003-03       Impact factor: 7.450

7.  Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a collaborative group report.

Authors:  Harry Herr; Cheryl Lee; Sam Chang; Seth Lerner
Journal:  J Urol       Date:  2004-05       Impact factor: 7.450

8.  Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy.

Authors:  Harry W Herr
Journal:  Urology       Date:  2003-01       Impact factor: 2.649

9.  Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference.

Authors:  D G Skinner
Journal:  J Urol       Date:  1982-07       Impact factor: 7.450

10.  Systematic mapping of nephroureterectomy specimens removed for urothelial cancer: pathological findings and clinical correlations.

Authors:  J P McCarron; S B Chasko; G F Gray
Journal:  J Urol       Date:  1982-08       Impact factor: 7.450

View more
  6 in total

1.  Risk of cancer-specific mortality following recurrence after radical nephroureterectomy.

Authors:  Michael Rink; Daniel Sjoberg; Evi Comploj; Vitaly Margulis; Evanguelos Xylinas; Richard K Lee; Jens Hansen; Eugene K Cha; Jay D Raman; Mesut Remzi; Karim Bensalah; Giacomo Novara; Surena F Matin; Felix K Chun; Eiji Kikuchi; Wassim Kassouf; Juan I Martinez-Salamanca; Yair Lotan; Christian Seitz; Armin Pycha; Richard Zigeuner; Pierre I Karakiewicz; Douglas S Scherr; Andrew J Vickers; Shahrokh F Shariat
Journal:  Ann Surg Oncol       Date:  2012-07-18       Impact factor: 5.344

Review 2.  The role of extensive lymphadenectomy in upper tract malignant disease.

Authors:  Travis Pagliara; Andrew Nguyen; Badrinath Konety
Journal:  Curr Urol Rep       Date:  2014-11       Impact factor: 3.092

3.  Patterns of Lymphatic Metastases in Upper Tract Urothelial Carcinoma and Proposed Dissection Templates.

Authors:  Surena F Matin; John P Sfakianos; Patrick N Espiritu; Jonathan A Coleman; Philippe E Spiess
Journal:  J Urol       Date:  2015-06-19       Impact factor: 7.450

4.  Template-based lymphadenectomy reduces the risk of regional lymph node recurrence among patients with upper/middle ureteral cancer.

Authors:  Tsunenori Kondo; Isao Hara; Toshio Takagi; Yoshiki Kodama; Yasunobu Hashimoto; Hirohito Kobayashi; Junpei Iizuka; Kenji Omae; Kazuhiko Yoshida; Kazunari Tanabe
Journal:  Int J Clin Oncol       Date:  2016-07-23       Impact factor: 3.402

Review 5.  Therapeutic role of template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract.

Authors:  Tsunenori Kondo; Toshio Takagi; Kazunari Tanabe
Journal:  World J Clin Oncol       Date:  2015-12-10

Review 6.  Optimal Management of Upper Tract Urothelial Carcinoma: Current Perspectives.

Authors:  Jeffrey J Leow; Zhenbang Liu; Teck Wei Tan; Yee Mun Lee; Eu Kiang Yeo; Yew-Lam Chong
Journal:  Onco Targets Ther       Date:  2020-01-06       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.